Evidence map›Paper›PMID 33204235›Full record

ArticleEngineering in life sciences2020

Performance evaluation of a high-throughput separation system for circulating tumor cells based on microcavity array.

Ryo Negishi, Hyuga Saito, Reito Iwata, Tsuyoshi Tanaka, Tomoko Yoshino

Abstract read
In one paragraph

Article in Engineering in life sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. In Vitro Radiobiological Evaluation of [Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryo NegishiDivision of Biotechnology and Life Science Institute of Engineering Tokyo University of Agriculture and Technology Tokyo Japan.
Hyuga SaitoDivision of Biotechnology and Life Science Institute of Engineering Tokyo University of Agriculture and Technology Tokyo Japan.
Reito IwataDivision of Biotechnology and Life Science Institute of Engineering Tokyo University of Agriculture and Technology Tokyo Japan.
Tsuyoshi TanakaDivision of Biotechnology and Life Science Institute of Engineering Tokyo University of Agriculture and Technology Tokyo Japan.
Tomoko YoshinoDivision of Biotechnology and Life Science Institute of Engineering Tokyo University of Agriculture and Technology Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are widely known as useful biomarkers in the liquid biopsies of cancer patients. Although single-cell genetic analysis of CTCs is a promising diagnostic tool that can provide detailed clinical information for precision medicine, the capacity of single-CTC isolation for genetic analysis requires improvement. To overcome this problem, we previously developed a multiple single-cell encapsulation system for CTCs using hydrogel-encapsulation, which allowed for the high-throughput isolation of single CTCs. However, isolation of a single cell from adjacent cells remained difficult and often resulted in contamination by neighboring cells due to the limited resolution of the generated hydrogel. We developed a novel multiple single-cell encapsulation system equipped with a high magnification lens for high throughput and a more accurate single-cell encapsulation. The multiple single-cell encapsulation system has sufficient sensitivity to detect immune-stained CTCs, and could also generate a micro-scaled hydrogel that can isolate a single cell from adjacent cells within 10 µm, with high efficiency. The proposed system enables high throughput and accurate single-cell manipulation and genome amplification without contamination from neighboring cells.

Indexed as

circulating tumor cells (CTCs)photopolymerizable hydrogelsingle‐cell analysiswhole genome amplification

Identifiers

PMID33204235
PMCPMC7645638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.